pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 11·1 min read
save

Actuaries predict continued rise in healthcare costs for next year

Jun 11, 2026·read at Endpoints ↗Negative

A recent survey of actuaries from 27 health plans that serve both employer groups and individual exchange markets shows early signs of where health-care spending is headed.

The respondents expect overall costs to keep climbing throughout the coming year, reflecting ongoing pressure from factors such as drug prices and service utilization.

These trends could influence budgeting decisions for employers and insurers, and may shape the environment in which pharmaceutical companies set prices and negotiate reimbursements.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “The seeming inevitability of rising healthcare costs”

read at Endpoints ↗
80 words · retrieved Jun 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING

related stories

  • May 13U.S. overdose deaths fell again in 2025, but some worry about policy and drug supply changesSTAT
  • May 13The ‘velocity of obesity’ aims to show which nations are slowing an epidemicSTAT
  • May 13Extreme heat is worsening faster for Black AmericansSTAT
  • May 13Opinion: Access to air conditioning is critical preventive care. But federal policy treats it as optionalSTAT
  • May 13STAT+: A new kind of liver crisis is emerging in the U.S. The American diet is to blameSTAT